HLB Pharmaceutical Co., Ltd. (KOSDAQ: A047920)
Health Care · Pharmaceuticals · KR
₩7,850.00
-10.80% today · -41.9% 1Y
HLB Pharmaceutical Co., Ltd. (KOSDAQ: A047920) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $79.54M.
Over the last twelve months the share price has lost 41.9%, trading between 6.00K and 22.25K.
Tweenvest scores HLB Pharmaceutical Co., Ltd. across four factors: quality 61/100, value 82/100. Its strongest factor is value.
A047920 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $79.54M
- Revenue (TTM)
- $162.69M
- P/E
- 94.32
- EPS
- 83.23
- Dividend yield
- —
- Beta (5Y)
- 0.26
- 52-week high
- ₩22,250.00
- 52-week low
- ₩6,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 14.04M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,231.78 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.81 | -0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.